Sharon K. Krueger

2.0k total citations
39 papers, 1.6k citations indexed

About

Sharon K. Krueger is a scholar working on Pharmacology, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Sharon K. Krueger has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Molecular Biology and 9 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Sharon K. Krueger's work include Pharmacogenetics and Drug Metabolism (15 papers), Carcinogens and Genotoxicity Assessment (8 papers) and Toxic Organic Pollutants Impact (7 papers). Sharon K. Krueger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Carcinogens and Genotoxicity Assessment (8 papers) and Toxic Organic Pollutants Impact (7 papers). Sharon K. Krueger collaborates with scholars based in United States, United Kingdom and Ireland. Sharon K. Krueger's co-authors include David E. Williams, Lisbeth K. Siddens, Marilyn C. Henderson, David E. Williams, Ronald N. Hines, Mei‐Fei Yueh, Clifford B. Pereira, Jan F. Stevens, Daniel R. Knapp and William M. Baird and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Sharon K. Krueger

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon K. Krueger United States	23	561	469	265	254	204	39	1.6k
Pier Giovanni Gervasi Italy	27	513 0.9×	719 1.5×	397 1.5×	340 1.3×	293 1.4×	83	1.8k
Amy L. Roe United States	18	592 1.1×	308 0.7×	562 2.1×	139 0.5×	326 1.6×	41	1.8k
Patricia E. Levi United States	21	365 0.7×	474 1.0×	267 1.0×	211 0.8×	191 0.9×	51	1.4k
Dennis V. Parke United Kingdom	23	547 1.0×	699 1.5×	308 1.2×	233 0.9×	340 1.7×	110	1.9k
Alan Wilson United States	26	575 1.0×	245 0.5×	126 0.5×	180 0.7×	227 1.1×	65	1.7k
Hideto Jinno Japan	26	843 1.5×	700 1.5×	451 1.7×	548 2.2×	176 0.9×	108	2.2k
Arun P. Kulkarni United States	24	956 1.7×	417 0.9×	302 1.1×	137 0.5×	176 0.9×	135	2.1k
Wolfgang W. Huber Austria	22	829 1.5×	214 0.5×	205 0.8×	184 0.7×	375 1.8×	32	2.0k
Ming‐Cheh Liu United States	24	854 1.5×	487 1.0×	141 0.5×	189 0.7×	64 0.3×	108	1.8k
Shizuo Nakajin Japan	26	1.0k 1.8×	906 1.9×	261 1.0×	261 1.0×	123 0.6×	86	2.9k

Countries citing papers authored by Sharon K. Krueger

Since Specialization

Citations

This map shows the geographic impact of Sharon K. Krueger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon K. Krueger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon K. Krueger more than expected).

Fields of papers citing papers by Sharon K. Krueger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon K. Krueger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon K. Krueger. The network helps show where Sharon K. Krueger may publish in the future.

Co-authorship network of co-authors of Sharon K. Krueger

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon K. Krueger. A scholar is included among the top collaborators of Sharon K. Krueger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon K. Krueger. Sharon K. Krueger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siddens, Lisbeth K., Sandra L. Uesugi, Tammie McQuistan, et al.. (2018). Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction. Food and Chemical Toxicology. 115. 136–147. 26 indexed citations

Siddens, Lisbeth K., Tammie McQuistan, Christiane V. Löhr, et al.. (2015). Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse. Toxicology and Applied Pharmacology. 287(2). 149–160. 29 indexed citations

Siddens, Lisbeth K., Sharon K. Krueger, Marilyn C. Henderson, & David E. Williams. (2014). Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide. Biochemical Pharmacology. 89(1). 141–147. 55 indexed citations

Henderson, Marilyn C., Lisbeth K. Siddens, Sharon K. Krueger, et al.. (2014). Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones. Toxicology and Applied Pharmacology. 278(2). 91–99. 13 indexed citations

Celius, Trine, Jason Matthews, Allan B. Okey, et al.. (2010). Flavin-containing monooxygenase-3: Induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. Toxicology and Applied Pharmacology. 247(1). 60–69. 32 indexed citations

Krueger, Sharon K., Marilyn C. Henderson, Lisbeth K. Siddens, et al.. (2009). Characterization of Sulfoxygenation and Structural Implications of Human Flavin-Containing Monooxygenase Isoform 2 (FMO2.1) Variants S195L and N413K. Drug Metabolism and Disposition. 37(8). 1785–1791. 8 indexed citations

Siddens, Lisbeth K., et al.. (2007). Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms. Biochemical Pharmacology. 75(2). 570–579. 23 indexed citations

Koukouritaki, Sevasti B., Mark Poch, Marilyn C. Henderson, et al.. (2006). Identification and Functional Analysis of Common Human Flavin-Containing Monooxygenase 3 Genetic Variants. Journal of Pharmacology and Experimental Therapeutics. 320(1). 266–273. 62 indexed citations

Krueger, Sharon K., et al.. (2006). The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines. Drug Metabolism Reviews. 38(1-2). 139–147. 46 indexed citations

10.

Krueger, Sharon K., Lisbeth K. Siddens, Marilyn C. Henderson, et al.. (2005). Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics. Pharmacogenetics and Genomics. 15(4). 245–256. 22 indexed citations

11.

Krueger, Sharon K. & David E. Williams. (2005). Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacology & Therapeutics. 106(3). 357–387. 425 indexed citations

12.

Henderson, Marilyn C., Sharon K. Krueger, Lisbeth K. Siddens, Jan F. Stevens, & David E. Williams. (2004). S-Oxygenation of the thioether organophosphate insecticides phorate and disulfoton by human lung flavin-containing monooxygenase 2. Biochemical Pharmacology. 68(5). 959–967. 51 indexed citations

13.

Traber, Maret G., Lisbeth K. Siddens, Scott W. Leonard, et al.. (2004). α-Tocopherol modulates Cyp3a expression, increases γ-CEHC production, and limits tissue γ-tocopherol accumulation in mice fed high γ-tocopherol diets. Free Radical Biology and Medicine. 38(6). 773–785. 80 indexed citations

14.

Lattard, Virginie, Christiane Longin‐Sauvageon, Sharon K. Krueger, David E. Williams, & Etienne Benoît. (2002). The FMO2 Gene of Laboratory Rats, as in Most Humans, Encodes a Truncated Protein. Biochemical and Biophysical Research Communications. 292(2). 558–563. 17 indexed citations

15.

Krueger, Sharon K., Sarah R. Martin, Mei‐Fei Yueh, Clifford B. Pereira, & David E. Williams. (2002). Identification of Active Flavin-Containing Monooxygenase Isoform 2 in Human Lung and Characterization of Expressed Protein. Drug Metabolism and Disposition. 30(1). 34–41. 40 indexed citations

16.

Krueger, Sharon K., et al.. (1999). Flavin-containing monooxygenase isoform 2: Developmental expression in fetal and neonatal rabbit lung. Journal of Biochemical and Molecular Toxicology. 13(3-4). 187–193. 6 indexed citations

17.

Krueger, Sharon K., Richard G. Ivey, Eric C. Henry, & Russel H. Meints. (1996). A Brown Algal Virus Genome Contains a “RING” Zinc Finger Motif. Virology. 219(1). 301–303. 9 indexed citations

18.

Ivey, Richard G., et al.. (1996). A Feldmannia Algal Virus Has Two Genome Size-Classes. Virology. 220(2). 267–273. 16 indexed citations

19.

Krueger, Sharon K., et al.. (1989). Combining Ability among Inbred Onions for Resistance to Fusarium Basal Rot. HortScience. 24(6). 1021–1023. 10 indexed citations

20.

Knapp, Daniel R. & Sharon K. Krueger. (1975). Use of O-p-Nitrobenzyl-N, N′-Diisopropylisourea as a Chromogenic Reagent for Liquid Chromatographic Analysis of Carboxylic Acids. Analytical Letters. 8(9). 603–610. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact